Aclarion, Inc.
ACONW- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- SEC CIK
- 0001635077
In the last 90 days, Aclarion, Inc. insiders filed 6 open-market purchases and 0 sales; 4 institutions reported holding it in 13F filings for Q2 2026, worth $3.08K in total; no superinvestor holds it.
Other share classesACON
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Aclarion, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 6 filings
- 6 insiders, $125.7K in total
- Open-market sells
- 0 filings
- Insiders trading
- 6
- Net value
- +$125.7K
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Aclarion, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Sequira Amanda Mae | Director | 25,857 | Aug 19, 2026 | 2 |
| Gould Gregory A | CFO | 60,000 | Aug 18, 2026 | 2 |
| Bond Ryan | Director | 76,122 | Aug 17, 2026 | 2 |
| Wesemann William | Director | 23,713 | Aug 17, 2026 | 3 |
| Neal David K | Director | 30,002 | Aug 17, 2026 | 3 |
| Ness Brent | Chief Executive Officer | 111,534 | Aug 17, 2026 | 4 |
| Deitsch Stephen | Director | 20,000 | Jun 12, 2026 | 1 |
| Thramann Jeffrey John | Executive Chairman | 100,000 | Jun 12, 2026 | 1 |
| Breidbart Scott | Director | 25,664 | Jun 12, 2026 | 2 |
| Lorbiecki John Paul | Chief Financial Officer | 22,404 | Dec 29, 2022 | 0 |
| Dirks Michael W | Other: Former 10% Owner | 0 | Dec 6, 2022 | 0 |
| SC Capital 1 LLC | Other: Former 10% Owner | 0 | Dec 6, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 19, 2026 (view filing)8:30 AM ET | Aug 17 | 2 days | Sequira Amanda MaeDirector | PPurchase | +5.86K | $2.73 | +$16.0K | +29.3%25.9K after | |
| Aug 18, 2026 (view filing)8:30 AM ET | Aug 14 | 4 days | Gould Gregory ACFO | PPurchase | +10.0K | $2.45 | +$24.5K | +20.0%60.0K after | |
| Aug 17, 2026 (view filing)8:30 AM ET | Aug 13 | 4 days | Bond RyanDirector | PPurchase | +21.1K | $2.37 | +$50.1K | +38.4%76.1K after | |
| Aug 17, 2026 (view filing)8:30 AM ET | Aug 13 | 4 days | Wesemann WilliamDirector | PPurchase | +2.15K | $2.34 | +$5.03K | +10.0%23.7K after | |
| Aug 17, 2026 (view filing)8:30 AM ET | Aug 13 | 4 days | Neal David KDirector | PPurchase | +7.50K | $2.40 | +$18.0K | +33.3%30.0K after | |
| Aug 17, 2026 (view filing)8:30 AM ET | Aug 13 | 4 days | Ness BrentChief Executive Officer | PPurchase | +5.23K | $2.31 | +$12.1K | +4.9%111.5K after | |
| May 12, 2026 (view filing) | May 12 | Same day | Breidbart ScottDirector | PPurchase | +5.66K | $3.18 | +$18.0K | New position5.66K after | |
| May 12, 2026 (view filing) | May 11 | 1 day | Neal David KDirector | PPurchase | +2.50K | $3.10 | +$7.75K | +125,000.0%2.50K after | |
| May 11, 2026 (view filing) | May 11 | Same day | Ness BrentChief Executive Officer | PPurchase | +6.29K | $3.18 | +$20.0K | +57,172.7%6.30K after | |
| May 8, 2026 (view filing) | May 6 | 2 days | Wesemann WilliamDirector | PPurchase | +1.56K | $3.30 | +$5.15K | +156,200.0%1.56K after | |
| Dec 1, 2025 (view filing) | Nov 26 | 5 days | Ness BrentChief Executive Officer | PPurchase | +10 | $6.20 | +$62 | +1,000.0%11 after | |
| Feb 21, 2023 (view filing) | Feb 16 | 5 days | Thramann Jeffrey JohnExecutive Chairman | PPurchaseSeries A Preferred Stock | +1 | $1,000.00 | +$1.00K | New position1 after | |
| Dec 29, 2022 (view filing)7:57 PM ET | Dec 28-29 | 1 day | Ness BrentChief Executive Officer | PPurchase | +18.5K | $0.528 | +$9.77K | +1,850.0%19.5K after | 3 lots |
| Dec 29, 2022 (view filing)6:27 PM ET | Dec 29 | Same day | Lorbiecki John PaulChief Financial Officer | PPurchase | +22.4K | $0.4463 | +$10.0K | New position22.4K after | 2 lots |
| Apr 25, 2022 (view filing) | Apr 21 | 4 days | Wesemann WilliamDirector | PPurchase | +11.0K | $4.35 | +$47.9K | +26.4%52.7K after | |
| Apr 25, 2022 (view filing) | Apr 21 | 4 days | Wesemann WilliamDirector | PPurchase | +11.0K | $0.00 | $0 | –21.0K after | Derivative |
| Apr 25, 2022 (view filing) | Apr 21 | 4 days | Ness BrentChief Executive Officer | PPurchase | +1.00K | $4.35 | +$4.35K | New position1.00K after | |
| Apr 25, 2022 (view filing) | Apr 21 | 4 days | Ness BrentChief Executive Officer | PPurchase | +1.00K | $0.00 | $0 | –342.4K after | Derivative |
| Apr 25, 2022 (view filing) | Apr 21 | 4 days | Neal David KDirector | PPurchase | +34.4K | $4.35 | +$149.6K | New position34.4K after | |
| Apr 25, 2022 (view filing) | Apr 21 | 4 days | Neal David KDirector | PPurchase | +34.4K | $0.00 | $0 | –104.7K after | Derivative |
| Apr 25, 2022 (view filing) | Apr 22 | 3 days | Bond RyanChief Strategy Officer | PPurchase | +20.0K | $2.80 | +$56.0K | New position20.0K after | |
| Apr 25, 2022 (view filing) | Apr 22 | 3 days | Bond RyanChief Strategy Officer | PPurchase | +21.0K | $0.73 | +$15.3K | –48.5K after | Derivative |